77007

Prognostic significance of fascin and Wilm’s tumor 1 (WT1) in oral squamous cell carcinomas – case control study

Article

Last updated: 01 Jan 2025

Subjects

-

Tags

-

Abstract

Aims: To elucidate the role of fascin and WT1 expression in oral squamous cell carcinoma (OSCC) by correlation with clinicopathological parameters.
Subjects and methods: Paraffin sections of 27 OSCC tissue were immunohistochemically stained with fascin and WT1 using the avidin-biotin-peroxidase staining method. Correlations between fascin and WT1 and various clinicopathological features, and prognosis were studied.
Results: Immunohistochemical study revealed significant increase of fascin and WT1 in OSCC in relation to control group (p< 0.000). Receiver operating characteristic (ROC) curve for fascin and WT1 were conducted for detection of recurrence. Fascin showed fair area under curve (AUC) (AUC=0.66), with sensitivity of 63.6 % and specificity of 50.0 % at cutoff value of 42.5 %. WT1 also showed fair AUC (AUC=0.63), with sensitivity of 63.6 % and specificity 68.8 % at cutoff value of 40.0 %. ROC curve for WT1 and fascin were conducted for detection of lymph node infiltration. While fascin showed excellent AUC (AUC=0.865), cutoff value of 52.5 %, with sensitivity of 70.0 % and specificity of 94.1%. WT1 also showed excellent AUC (AUC=0.791), cutoff value of 42.2 %, with sensitivity of 70.0 % and specificity 70.6%. Significant associations were detected between median fascin cutoff value at 45% and well differentiated tumor (P=0.04), T3&T4 tumor size (P= 0.01), LN infiltration (P=0.05), and tumor-node metastasis 3 and 4 (TNM3 &TNM4) staging (P=0.02). Significant associations were found between the median cutoff value of WT1 and moderately differentiated tumor (P=0.02), and LN infiltration (P=0.01). The 2-year survival rate of patients with fascin of ≥ 45% and WT1 ≥ 40% were nonsignificantly higher than that of patients with fascin of < 45% and WT1 <40% (P=0.09, P=0.55). Univariate analysis demonstrated that Fascin, WT1 were significant risk factors of LN (p=0.005, 0.02) but not considered as risk factors of tumor recurrence.
Conclusion: Fascin and WT1 have oncogenic effects playing an important role in progression of OSCC. Overexpression of them contributes to a more aggressive clinical course. Understanding their role on OSCC and other tumors will facilitate the development of new treatment strategies.

DOI

10.21608/edj.2018.77007

Keywords

Oral squamous cell carcinoma, fascin, Wilm's tumor 1 (WT1), tumor markers

Authors

First Name

Samah

Last Name

El-Meadawy

MiddleName

H.

Affiliation

Associate Professor of Oral Medicine and Periodontology, Department of Oral Medicine, Periodontology, Oral Diagnosis , and Radiology, Faculty of Dentistry, Mansoura University.

Email

-

City

-

Orcid

-

First Name

Naglaa

Last Name

Salama

MiddleName

M.

Affiliation

Associate Professor of Oral Pathology, Oral Pathology Department, Faculty of Dentistry, Mansoura University

Email

-

City

-

Orcid

-

First Name

Lobna

Last Name

Radwan

MiddleName

R.S.

Affiliation

Associate Professor of Oral Biology, Oral Biology Department, Faculty of Dentistry, Mansoura University

Email

-

City

-

Orcid

-

First Name

Mahmoud

Last Name

El-sherbiny

MiddleName

-

Affiliation

Assistant Professor of Oral Pathology, Oral Pathology Department, Faculty of Dentistry, Mansoura University

Email

-

City

-

Orcid

-

Volume

64

Article Issue

Issue 2 - April (Oral Medicine, X-Ray, Oral Biology & Oral Pathology)

Related Issue

11447

Issue Date

2018-04-01

Receive Date

2020-03-11

Publish Date

2018-04-01

Page Start

1,187

Page End

1,202

Print ISSN

0070-9484

Online ISSN

2090-2360

Link

https://edj.journals.ekb.eg/article_77007.html

Detail API

https://edj.journals.ekb.eg/service?article_code=77007

Order

6

Type

Original Article

Type Code

254

Publication Type

Journal

Publication Title

Egyptian Dental Journal

Publication Link

https://edj.journals.ekb.eg/

MainTitle

Prognostic significance of fascin and Wilm’s tumor 1 (WT1) in oral squamous cell carcinomas – case control study

Details

Type

Article

Created At

22 Jan 2023